J B Chemicals & Pharma gets USFDA approval for hypertension tablets
J B Chemicals & Pharmaceuticals receives approval from US health regulator for Atenolol tablets, which is used for treating high blood pressure. In a BSE...
Tag : receives
Dr Reddy’s receives EIR for Bachupally unit from USFDA
Dr Reddy’s Laboratories has received an establishment inspection report (EIR) for Bachupally unit, Hyderabad, after the closure of its audit from the US Food and Drug...
Capital First receives panel approval for raising Rs.400 cr through NCDs
Capital First, has received approval to raise up to Rs.400 crore via issuance of non-convertible debentures (NCDs) on private placement basis, from its debenture committee....
Cadila receives USFDA approval for drug that treats schizophrenia
Cadila Healthcare’s subsidiary, has received approval from the US health regulator for Clozapine tablets, which is used to treat schizophrenia. In a filing the company stated,...
Hatsun Agro receives board approval for fund raising worth Rs.900 cr
Hatsun Agro Products has received approval from its board, to raise funds up to Rs.900 crore, in a meeting held yesterday on December 6. Funds will...
Shilpa Medicare receives 10 observations for Telangana facility
Shilpa Medicare has received Form no 483 observations, related to SEZ formulation facilities situated at Jadcherla, Telangana, from the United States Food & Drug Administration (USFDA)....
Dr Reddy’s receives EIR for Telangana unit, from USFDA
Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR), for its Miyapur facility, Hyderabad, Telangana. The Custom Pharmaceutical Services facility, of Dr Reddy’s Laboratories at the...
Biocon, Mylan receives approval for biosimilar version of Herceptin
USFDA has given approval to Mylan’s Ogivri, which is a biosimilar of cancer drug Herceptin, co-developed with Biocon. Trastuzumab is the generic name of Herceptin. Ogivri has received...
DLF receives approval from the board for QIP
DLF has received approval from its board for a qualified institutional placement (QIP) and a capital infusion plan. The approval has been received for raising...
Dr Reddy’s receives first cycle approval for psoriasis treatment
Dr Reddy’s Laboratories has received first cycle new drug application (NDA) approval, from the US health regulator, for its Impoyz cream used for treating psoriasis....